Clear Trail Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Clear Trail Advisors's AMGN Position: Q3 2026 in Review
Clear Trail Advisors increased its Amgen (AMGN) stake by 17% in Q3 2026, buying an estimated $646K and bringing the position to 11,377 shares worth $4.8M. The position accounts for 0.73% of the portfolio, ranked #43.
Clear Trail Advisors first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 3,268 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Clear Trail Advisors held 11,377 shares of Amgen worth $4.8M as of Q3 2026.
- Clear Trail Advisors bought 1,622 Amgen shares in Q3 2026, an estimated $646K.
- Amgen made up 0.73% of Clear Trail Advisors's portfolio in Q3 2026, its #43 holding.
- Clear Trail Advisors first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
- 3,268 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Clear Trail Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.